Repatha is a drug intended to treat patients with high cholesterol. The Pushotronex system offers a new, monthly single-dose administration option for the drug.
The device, created in conjunction with West Pharmaceutical Services in Exton, Pa., attaches to the body, allowing for hands-free administration.
The medicine may also be administered twice a week through the SureClick autoinjector.
Amgen, based in Thousand Oaks, Calif., expects the Pushtronex system to hit the market in early August.
More articles on supply chain:
Anti-HIV drug largely underused in San Francisco: 5 things to know
Drug monitoring programs show reduction in opioid overdoses: 6 things to know
FDA stops Juno’s cancer drug trials after 3 patients die
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
